NGL Fine-Chem Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
February 12, 2024 at 08:30 am EST
Share
NGL Fine-Chem Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 879.52 million compared to INR 719.35 million a year ago. Revenue was INR 916.31 million compared to INR 726.23 million a year ago. Net income was INR 100.34 million compared to INR 64.87 million a year ago. Basic earnings per share from continuing operations was INR 16.24 compared to INR 10.5 a year ago. Diluted earnings per share from continuing operations was INR 16.24 compared to INR 10.5 a year ago.
For the nine months, sales was INR 2,392.27 million compared to INR 2,002.58 million a year ago. Revenue was INR 2,493.92 million compared to INR 2,067.39 million a year ago. Net income was INR 290.18 million compared to INR 115.11 million a year ago. Basic earnings per share from continuing operations was INR 46.97 compared to INR 18.63 a year ago. Diluted earnings per share from continuing operations was INR 46.97 compared to INR 18.63 a year ago.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL FINE-CHEM LIMITED 
